Wikipedia -WSS

Wikipedia

author：knowledge 2025-10-02 23:45:43 - browse：9832

An Ozempic pen connects dots that make up the shape o a brain — coverage from STAT — ILLUSTRATION: CHRISTINE KAO/STAT; PHOTOS: ADOBE

Drugs like Ozempic and Wegovy — already game changers for diabetes and obesity — are being studied to treat an entirely different growing health problem: mental health illnesses, including depression and bipolar disorder.

Early data and anecdotes suggest that this class of GLP-1 drugs could help patients feel less depressed and anxious. The treatment may also fight the decline in cognitive and executive function that many people with mental health disorders experience, like worsening memory and losing the ability to focus and plan.

If further research yields positive results, it could drive even more demand for the highly popular GLP-1 treatments, which have increasingly been shown to help with problems across the body, such as heart and kidney complications. And especially if the cognitive benefits are proven out, the GLP-1 drugs would plug a critical gap in current treatments for depression, since most depression drugs help with mood, but close to none address cognitive symptoms that affect memory and attention.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Option Care buys Amedisys in $3.6 billion home care deal

hotspot

WSS

Option Care buys Amedisys in $3.6 billion home care deal

Readout Newsletter: Zepbound, Valneva's vaccine, and more

Meta looks to target Twitter with a rival app called Threads

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

Study suggests Covid rebound is far more common with Paxlovid than without

A letter from the executive editor: STAT UnitedHealth investigation

hotspot

Wikipedia

entertainment

Guidelines to prevent youth baseball injuries need more muscle

Van's Gluten Free Original Waffles recalled for possible wheat allergen

Sports medicine is finally prioritizing gender equality

How state and local governments are sidelining science

How to save PrEP access — and even expand it

Study suggests Covid rebound is far more common with Paxlovid than without

Medicare details structure of new drug price negotiation program

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

Walensky prepares to leave CDC — and Congress — behind

Australia's humpback populations rebound raising hopes of marine scientists

explore

Readout Newsletter: Zepbound, Valneva's vaccine, and more

Type 2 diabetes prevention programs work at large scale: study

After decades in use, heart stents finally beat placebo

First transplant of an entire human eye performed

How state and local governments are sidelining science

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

knowledge

explore

hotspot

knowledge